NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Certis Oncology Solutions

Certis Oncology Solutions

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.certisoncology.com/

Last Round

Series C

Jan 17, 2024

Total Funding Raised

$10M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Certis Oncology Solutions is a life science technology company that provides precision oncology services and AI-driven therapeutic response data to inform drug development and treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

patient-derived xenograftPDXprecision oncologycontract research organizationCROoncology drug developmentpreclinical researchpredictive AIbiomarker analysisdrug efficacytranslational medicineAI-driven drug discoveryin vivo modelingagentic AIbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Certis Oncology Solutions Comparables

Compare Certis Oncology Solutions with similar companies based on industry and business-model similarity.

Certis Oncology Solutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Champions Oncology
82%
Noble Life Sciences
79%
XenTech SAS
77%

Certis Oncology Solutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 17, 2024
Series AJun 1, 2017

Key People

Founding team and executive leadership

Peter Ellman

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2026

    Oncology Intelligence platform integrates AI with biological validation.

  • Feb 11, 2025

    Partnered with Provoke Agency.

Certis Oncology Solutions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Certis Oncology Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Certis Oncology Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range38
Year Founded2016
Last FundingJan 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.